Atlas Trials

Program of Angiotensin-Neprilysin Inhibition in Admitted Patients With Worsening Heart Failure (PREMIER)

Clinical trial NCT05164653 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT05164653
Sponsor
Saga University
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 4
Study type
INTERVENTIONAL
Heart Failure
Start date
2021-12-27
Primary completion
2024-02-08
Enrollment
400

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.